[Temporary Announcement] KGI Biotech: Announcement on Uncovered Losses Reaching One-Third of the Total Paid-In Share Capital
Announcement number: 2026-046
Securities code: 835272 Securities abbreviation: KGI Biotech Sponsoring broker: Kaiyuan Securities
Jiangsu Kaiji Biotechnology Co., Ltd.
Announcement on Uncovered Losses Reaching One-third of Total Paid-In Share Capital
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.
1. Overview of the situation
As of June 30, 2026, the company's audited financial statements total undistributed profits -
46,001,161.06 yuan, and the total paid-in share capital was 59,979,000.00 yuan. The uncovered losses exceeded one-third of the total paid-in share capital. Therefore, the company held the 13th meeting of the fourth board of directors on August 20, 2026 to review the proposal "About Uncovered Losses Reaching One-third of the Total Paid-In Share Capital" and proposed to the company to convene the second extraordinary shareholders' meeting in 2026 for review.
2. Reasons and countermeasures for unrecovered losses reaching one-third of the total paid-in share capital
The main reason is that the company had large unrecovered losses in previous years. During the reporting period, although the main business income increased compared with the previous period and profits increased, the losses in the previous period were relatively large and the previous losses could only be made up year by year. The company will focus on its main business to actively enhance its profitability and enhance its value and shareholder returns.
4. Documents for reference
"Resolution of the Thirteenth Meeting of the Fourth Board of Directors of Jiangsu Kaiji Biotechnology Co., Ltd."
Board of Directors of Jiangsu Kaiji Biotechnology Co., Ltd.
August 20, 2026